Mayo Clinic
In Brief This Week: MDxHealth, ERS Genomics, Helix, Cerca Biotech, Shuwen Biotech, More
News items for the week of Jan. 13, 2025.
BRCA2 Variants Classified in Saturation Genome Editing Studies
Research teams relied on CRISPR-Cas9-based editing and sequencing to perform high-throughput function evaluations of loss-of-function variants in exons 15 to 26 of BRCA2.
Data from Myriad Genetics offered early validation evidence for an expanded version of its commercial test, as well as a look into clinical impact via claims data.
Genomadix, Mayo Clinic Partner on CYP2C19 Testing for Remote Care For Stroke Patients
The partnership is intended to help expand adoption of the company's rapid PCR system in sites that treat stroke patients, including through telemedicine platforms.
Aignostics Raises $34M in Series B Round
The company develops AI technologies to analyze a range of pathology data derived from tissue samples for biopharma clients.